Latest filing published 15 Jun 2023 for Biocryst Pharmaceuticals INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Kenneth B. Lee Jr. span 3 companies, the busiest being Biocryst Pharmaceuticals Inc, Hyperion Defi, Inc. and Aralez Pharmaceuticals Inc. The record holds 9 filings, for trades running from 5 February 2016 to 13 June 2023.
Every open-market trade on record is a purchase: 2 purchases worth €30k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 4 share grants and 2 option exercises.
Most recently, on 15 June 2023, the filings show a share grant in Biocryst Pharmaceuticals Inc. The latest purchase dates back some time: it was published 1,609 days ago, on 23 May 2022. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations